Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024)

Palvella Therapeutics (PVLA) has 11 years of Receivables - Net data on file, last reported at $358000.0 in Q4 2024.

• Receivables - Net for Q4 2024 came in at $358000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $358000.0 (changed N/A YoY), and the FY2024 annual result was $358000.0, changed N/A from the prior year.
• Receivables - Net slipped to $358000.0 in Q4 2024 per PVLA's latest filing, from $500000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $17.0 million in Q2 2021 and troughed at $358000.0 in Q4 2024.
• A 5-year average of $4.9 million and a median of $1.7 million in 2020 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2021 and 2022: Receivables - Net jumped 477.45% in 2021, then plunged 95.12% in 2022.
• A 5-year view of Receivables - Net shows it stood at $1.7 million in 2020, then soared by 94.2% to $3.3 million in 2021, then surged by 75.37% to $5.8 million in 2022, then sank by 82.01% to $1.0 million in 2023, then slumped by 65.74% to $358000.0 in 2024.
• Business Quant data shows PVLA's Receivables - Net at $358000.0 in Q4 2024, $500000.0 in Q3 2024, and $1.5 million in Q2 2024.